Markets › Super Investors › Shanghvi Finance Private Limited
SL
Shanghvi Finance Private Limited
Corporate / BodyDisclosed Indian equity holdings above the 1% filing threshold.
Disclosed value
₹1.83 L Cr
Today
+₹2,381.1 Cr +1.32%
Companies
2
As of
19 May 2026
Returns vs NIFTY current basket, 1 year
This portfolio +10.9% NIFTY 50 -4.4%ahead of NIFTY by 15.3 pts
Today’s disclosed holdings valued back over the past year vs the NIFTY 50, rebased to 0%. Not a record of actual trades.
Sector allocation
Portfolio X-ray
Top-5 weight
100%
Wtd P/E
38.2
Wtd ROE
15.6%
Holdings
2
By market cap
Large 98% Mid 2% Small 0%
Holdings · 2
| Company▾ | Stake▾ | Value▼ | Today▾ | Q/Q▾ | P/E▾ | ROE▾ |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical SUNPHARMA · Healthcare | 40.30% | ₹1,80,152.1 Cr | +1.34% | – | 38.9 | 14% |
| Sun Pharma Advanced Research Company Ltd SPARC · Healthcare | 42.28% | ₹3,266.1 Cr | -0.03% | – | 5.0 | 116% |
Stake history by quarter (%) increased trimmed
| Company | Mar '26 | Dec '25 | Sept '25 | Jun '25 |
|---|---|---|---|---|
| Sun Pharmaceutical | 40.30 | 40.30 | 40.30 | 40.30 |
| Sun Pharma Advanced Research Company Ltd | 42.28 | 42.28 | 42.28 | · |
Holdings are taken exactly as filed in public shareholding disclosures, shown only once a stake crosses the 1% disclosure threshold, so this is the holder’s large positions, not every holding. Value = disclosed shares × latest market price, so it moves daily while share counts update each quarter; “Q/Q” compares with the prior filing (pp = percentage points). Names are shown as filed and folded only for capitalisation and spacing, never different spellings; a common name could, in principle, represent more than one person. For information only, not investment advice.